Pharmacotherapy A Pathophysiologic Approach. Pharmacotherapy. - 7th. Edition - Philadelphia | The McGraw-Hill Companies, Inc | 2008 - 2597 Pagges Includes Index

Job: Dipiro et al.: Pharmacotherapy: A Pathophysiologic Approach, 7e back cover copy; 9780071478991; 007147899X

[title]

Pharmacotherapy:

A Pathophysiologic Approach

Seventh Edition

[authors]

Joseph T. DiPiro

Robert L. Talbert

Gary C. Yee

Gary R. Matzke

Barbara G. Wells

L. Michael Posey

[Burst:]

Additional Chapters Available Online!

[headline]

The benchmark evidence-based pharmacotherapy text-now in full color!

When it comes to helping you develop a mastery of evidence-based medicine for optimal patient outcomes, no book can match Pharmacotherapy: A Pathophysiologic Approach. Like the discipline it covers, the scope of this trusted resource goes beyond drug indications and dosages to include the initial selection, proper administration, and monitoring of drugs.

The book also delves into psychosocial issues that affect compliance ... topics related to a patient's ability to understand and manage often-complex therapy... and lifestyle changes that may reduce the need for drug therapy or improve pharmacotherapeutic outcomes. Pharmacotherapy delivers everything you need to provide safe, efficacious drug therapy across the full range of therapeutic categories.

FEATURES

NEW! Expanded evidence-based recommendations NEW! Extended coverage of the timely issue of palliative care and pain medicine NEW! Important chapters on Pulmonary Hypertension, Disorders of Calcium and Phosphorus Homeostasis, and Multiple Myeloma, Outstanding pedagogy, including: “Key Concepts” highlighted in each chapter “Clinical Presentation” boxes summarize the most common disease signs and symptoms covered in each chapter “Clinical Controversies” boxes-presented in the Treatment sections of the disease-oriented chapters-examine the complicated issues faced by students and clinicians in providing drug therapy Clear therapeutic recommendations in each disease-specific chapter “Evaluation of Therapeutic Outcomes” boxes in each disease-specific chapter, containing key monitoring guidelines that facilitate the development of a pharmaceutical, nursing, or medical care plan
[McGraw-Hill Medical logo]

0-07-164325-7 0-07-147899-X. = Pharmacotherapy A Pathophysiologic Approach ACE inhibitors activity acute administration agents aldosterone amiodarone angina angiotensin antiarrhythmic anticoagulation antihypertensive ARB arrhythmias aspirin assessment associated atrial fibrillation bivalirudin bleeding blood flow blood pressure BP calcium channel blocker Cardiol Cardiovascular Disorders cause Chapter cholesterol chronic Clin clinical trials clopidogrel contraindications coronary artery disease creatinine decrease diabetes diastolic digoxin diltiazem diuretic dosage dose drug therapy dysfunction ECG Engl enoxaparin enzyme evaluation fondaparinux function gene guidelines heart disease heart failure heart rate hemodynamic heparin hospital hypertension hypotension increased infusion initial INR intravenous ischemia ischemic LDL left ventricular LMWH LV metabolism mg monitoring mortality myocardial infarction oral outcomes patients PCI pediatric pharmacokinetic pharmacologic Pharmacotherapy Pharmacy PharmD platelet poisoning prevention protein pulmonary receptor recommended reduced renal result rhythm risk factors SECTION 2 Cardiovascular sinus sodium ẞ-blockers stroke studies symptoms syndrome systolic Table tachycardia therapeutic thromboembolism thrombosis tion tissue toxicity treatment UFH vascular vasodilation venous verapamil VTE warfarin

--Medical / Pharmacy, Medical / Chemotherapy, Medical / Pathophysiology, Chemotherapy, Physiology, Pathological